Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Solvonis Therap (SVNS) Share Price

Price 0.315p on 18-07-2025 at 18:50:08
Change -0.005p -1.56%
Buy 0.32p
Sell 0.31p
Buy / Sell SVNS Shares
Last Trade: Buy 500,000.00 at 0.317p
Day's Volume: 68,134,929
Last Close: 0.315p
Open: 0.32p
ISIN: GB00BMD1Z199
Day's Range 0.315p - 0.34p
52wk Range: 0.087p - 0.365p
Market Capitalisation: £25.15m
VWAP: 0.321878p
Shares in Issue: 7.98b

Solvonis Therap (SVNS) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 500,000 0.317p Ordinary
16:05:31 - 18-Jul-25
Buy* 3,070 0.317p Ordinary
15:18:35 - 18-Jul-25
Buy* 58,742 0.317p Ordinary
14:49:30 - 18-Jul-25
Sell* 1,000,000 0.312p Ordinary
14:47:50 - 18-Jul-25
Buy* 1,110 0.317p Ordinary
14:47:47 - 18-Jul-25
Sell* 750,000 0.3125p Ordinary
14:18:46 - 18-Jul-25
Sell* 98,908 0.312p Ordinary
14:10:21 - 18-Jul-25
Sell* 201,443 0.313p Ordinary
13:39:28 - 18-Jul-25
Buy* 1,700 0.32p SI Trade
13:29:30 - 18-Jul-25
Buy* 10,000 0.32p SI Trade
13:29:30 - 18-Jul-25
See more Solvonis Therap trades

Solvonis Therap (SVNS) Share Price History

Time period:
to
Date Open High Low Close Volume
18th Jul 2025 (Fri) 0.32 0.34 0.315 0.315 68,134,929
17th Jul 2025 (Thu) 0.33 0.33 0.31 0.32 92,957,707
16th Jul 2025 (Wed) 0.36 0.33 0.31 0.33 175,904,261
15th Jul 2025 (Tue) 0.35 0.365 0.345 0.36 102,740,842
14th Jul 2025 (Mon) 0.33 0.36 0.36 0.36 181,460,795
11th Jul 2025 (Fri) 0.30 0.33 0.33 0.33 149,063,178
10th Jul 2025 (Thu) 0.28 0.295 0.28 0.29 31,953,226
9th Jul 2025 (Wed) 0.27 0.28 0.27 0.28 32,770,369
8th Jul 2025 (Tue) 0.255 0.27 0.27 0.27 73,788,874
7th Jul 2025 (Mon) 0.295 0.27 0.25 0.255 149,004,543
4th Jul 2025 (Fri) 0.295 0.305 0.295 0.295 172,948,860
3rd Jul 2025 (Thu) 0.284 0.315 0.28 0.296 285,888,627
2nd Jul 2025 (Wed) 0.245 0.296 0.245 0.295 144,894,045
1st Jul 2025 (Tue) 0.24 0.28 0.245 0.272 282,783,248
30th Jun 2025 (Mon) 0.215 0.255 0.215 0.24 198,347,528
27th Jun 2025 (Fri) 0.195 0.235 0.20 0.215 201,223,805
26th Jun 2025 (Thu) 0.18 0.195 0.18 0.19 87,736,116
25th Jun 2025 (Wed) 0.18 0.18 0.18 0.18 40,088,697
24th Jun 2025 (Tue) 0.19 0.19 0.18 0.18 31,608,019
23rd Jun 2025 (Mon) 0.18 0.205 0.175 0.19 121,498,494
20th Jun 2025 (Fri) 0.175 0.1735 0.1735 0.1735 64,075,464
See more Solvonis Therap price history

Solvonis Therap (SVNS) Regulatory News

Date Source Headline
18th Jul 2025 11:03 am RNS Exercise of warrants
14th Jul 2025 7:00 am RNS-R Solvonis Chair to speak at Lucid Capital Markets
11th Jul 2025 7:00 am RNS £1m subscription to accelerate AI drug discovery
8th Jul 2025 7:00 am RNS Holding(s) in Company
27th Jun 2025 2:38 pm RNS AGM Statement
27th Jun 2025 8:54 am RNS Holding(s) in Company
26th Jun 2025 10:21 am RNS-R Initiation of Research Coverage
23rd Jun 2025 7:00 am RNS Allowance of U.S. patent covering AI-supported CNS
11th Jun 2025 7:30 am RNS Initiation of AI supported CNS drug discovery
5th Jun 2025 7:00 am RNS Synthesis of development candidate for SVN-SDN-014
See more Solvonis Therap regulatory news

Solvonis Therap (SVNS) Share News

LONDON MARKET MIDDAY: Stocks red as "real concerns" on tariffs remain

11th Jul 2025 12:00

(Alliance News) - Stock prices in London were lower midday on Friday, after news of Donald Trump floating up to 20% blanket tariffs on some countries, and saying Canada will face a 35% levy effective from his latest August 1 deadline. Read More

SMALL-CAP WINNERS & LOSERS: Solvonis raises GBP1 million at premium

11th Jul 2025 10:35

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday. Read More

Solvonis Therapeutics raises GBP1.0 million for drug discovery scheme

11th Jul 2025 10:07

(Alliance News) - Solvonis Therapeutics PLC on Friday said it raised GBP1.0 million gross from subscriptions to new shares, and this will fund development of drugs treating addiction and other mental health disorders. Read More

Solvonis granted US patent for AI-led CNS compound programme

23rd Jun 2025 11:12

(Alliance News) - Solvonis Therapeutics PLC on Monday said the US Patent & Trademark Office has allowed a core patent application covering compounds in its artificial-intelligence-enabled central-nervous-system discovery programme, granting protection in the US's drug market for at least 18 years. Read More

UK shareholder meetings calendar - next 7 days

20th Jun 2025 12:02

Read More

See more Solvonis Therap news
FTSE 100 Latest
Value8,992.12
Change19.48

Login to your account

Forgot Password?

Not Registered